Evidence map›Paper›PMID 39483916›Full record

ArticleResearch square2024

PGLYRP-1 mediated intracellular peptidoglycan detection promotes mucosal protection.

Shuyuan Chen, Rachel Putnik, Xi Li, Alka Diwaker, Marina Vasconcelos, Shuzhen Liu, Junhui Zhou, Lei Guo, Lin Xu, Sebastian Temme and 7 more

Abstract readPreprint
In one paragraph

Article in Research square, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

17 authors.

Shuyuan ChenDepartment of Medicine, Division of Digestive and Liver Diseases, University of Texas Southwestern Medical Center, 5959 Harry Hines Boulevard, Dallas, Texas 75390, United States.
Rachel PutnikDepartment of Chemistry and Biochemistry, University of Delaware, Newark, Delaware 19716, United States National Cancer Institute.
Xi LiDepartment of Medicine, Division of Digestive and Liver Diseases, University of Texas Southwestern Medical Center, 5959 Harry Hines Boulevard, Dallas, Texas 75390, United States.
Alka DiwakerDepartment of Medicine, Division of Digestive and Liver Diseases, University of Texas Southwestern Medical Center, 5959 Harry Hines Boulevard, Dallas, Texas 75390, United States.
Marina VasconcelosDepartment of Chemistry and Biochemistry, University of Delaware, Newark, Delaware 19716, United States National Cancer Institute.ORCID 0009-0000-9178-9841
Shuzhen LiuDepartment of Medicine, Division of Digestive and Liver Diseases, University of Texas Southwestern Medical Center, 5959 Harry Hines Boulevard, Dallas, Texas 75390, United States.
Junhui ZhouDepartment of Chemistry and Biochemistry, University of Delaware, Newark, Delaware 19716, United States National Cancer Institute.
Lei GuoQuantitative Biomedical Research Center, Peter O'Donnell Jr. School of Public Health, University of Texas Southwestern Medical Center, United States.
Lin XuQuantitative Biomedical Research Center, Peter O'Donnell Jr. School of Public Health, University of Texas Southwestern Medical Center, United States.ORCID 0000-0001-5815-4457
Sebastian TemmeChemical Biology Laboratory, Center for Cancer Research, National Cancer Institute, Frederick, MD, 21702, United States.ORCID 0000-0001-8306-2810
Klare BerschDepartment of Chemistry and Biochemistry, University of Delaware, Newark, Delaware 19716, United States National Cancer Institute.
Stephen HylandDepartment of Chemistry and Biochemistry, University of Delaware, Newark, Delaware 19716, United States National Cancer Institute.
Jianyi YinDepartment of Medicine, Division of Digestive and Liver Diseases, University of Texas Southwestern Medical Center, 5959 Harry Hines Boulevard, Dallas, Texas 75390, United States.
Ezra BursteinDepartment of Medicine, Division of Digestive and Liver Diseases, University of Texas Southwestern Medical Center, 5959 Harry Hines Boulevard, Dallas, Texas 75390, United States.ORCID 0000-0003-4341-6367
Jeffrey C GildersleeveChemical Biology Laboratory, Center for Cancer Research, National Cancer Institute, Frederick, MD, 21702, United States.
Catherine Leimkuhler GrimesDepartment of Chemistry and Biochemistry, University of Delaware, Newark, Delaware 19716, United States National Cancer Institute.ORCID 0000-0002-0586-2879
Hans-Christian ReineckerDepartment of Medicine, Division of Digestive and Liver Diseases, University of Texas Southwestern Medical Center, 5959 Harry Hines Boulevard, Dallas, Texas 75390, United States.ORCID 0000-0001-8283-644X

Funding

Structural Biology CoreP01AI172525 · NIAID · SCRIPPS RESEARCH INSTITUTE, THE · PI IAN A WILSON · 2023 to 2026
$9.9M
Innate Immune Defense Mechanisms in the IntestineR01AI113333 · NIAID · UT SOUTHWESTERN MEDICAL CENTER · PI REINECKER, HANS-CHRISTIAN · 2014 to 2025
$5.7M
Chemistry-Biology Interface Predoctoral Training Grant 2024-2029T32GM133395 · NIGMS · UNIVERSITY OF DELAWARE · PI Catherine Leimkuhler Grimes · 2019 to 2026
$3.7M
Peptidoglycan Fragment Library to Investigate Innate Immune ResponsesR01GM138599 · NIGMS · UNIVERSITY OF DELAWARE · PI GRIMES, CATHERINE LEIMKUHLER, REINECKER, HANS-CHRISTIAN · 2020 to 2023
$2.0M
NIAID NIH HHS P01 AI172525NIAID NIH HHS R01 AI113333NIGMS NIH HHS R01 GM138599NIGMS NIH HHS T32 GM133395
6 · The paper itself

Abstract

Peptidoglycan recognition proteins (PGRPs or PGLYRPs) are implicated in the control of the intestinal microbiota; however, molecular requirements for peptidoglycan (PGN) binding and receptor signaling mechanisms remain poorly understood. We identified PGLYRP-1 as a receptor for the disaccharide motif of lysine N-acetylglucosamine N-acetylmuramic tripeptide (GMTriP-K) with a newly constructed PGN microarray. Surprisingly, PGLYRP-1 was required for innate immune activation of macrophages by GMTriP-K but not N-acetylglucosamine N-acetylmuramic dipeptide (GMDiP) or muramyl dipeptide (MDP). In macrophages, intracellular PGLYRP-1 complexed with NOD2 and GEF-H1, both of which were required for GMTriP-K-regulated gene expression. PGLYRP-1 localized to the endoplasmic reticulum and interacted at the Golgi with NOD2 upon GMTriP-K stimulation. PGLYRP-1 upregulation and its dependent gene expression signatures were induced in both mouse intestinal inflammation and human ulcerative colitis. Importantly, PGLYRP-1 activation by GMTriP-K resulted in innate immune activation and protection of mice from colitis. Our results show that PGLYRPs can function as intracellular PGN pattern recognition receptors for the control of host defense responses in the intestine.

Identifiers

PMID39483916
PMCPMC11527351

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.